Cite
HARVARD Citation
Mohamed, M. et al. (n.d.). AB0432 ABT-494 has no effect on the QT interval at the doses being evaluated in rheumatoid arthritis phase 3 trials. Annals of the rheumatic diseases. p. 1201. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mohamed, M. et al. (n.d.). AB0432 ABT-494 has no effect on the QT interval at the doses being evaluated in rheumatoid arthritis phase 3 trials. Annals of the rheumatic diseases. p. 1201. [Online].